Skip to Main Content

Paper Details

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.
Alzheimers Dement
27
2020
C9orf72, Dementia, Executive dysfunction, FTLD, Familial FTLD, Familial Frontotemporal Dementia, Frontotemporal Lobar Degeneration, GRN, MAPT, familial FTLD, familial frontotemporal dementia, frontotemporal lobar degeneration
Author NameAffiliation
John KornakUniversity of California san francisco
Brian S ApplebyCase Western Reserve University
Giovanni CoppolaUniversity of California los angeles
Giovanni CoppolaUniversity of California los angeles
Tatiana ForoudIndiana University
Jonathan Graff-RadfordMayo Clinic
Neill R Graff-RadfordMayo Clinic
Ging-Yuek R HsiungUniversity of British Columbia
Anna KarydasUniversity of California san francisco
Diana R KerwinCenter for Alzheimer's and Neurodegenerative Diseases, The University of Texas, Southwestern Medical Center at Dallas
Diana R KerwinThe University of Texas, Southwestern Medical Center at Dallas
David S KnopmanMayo Clinic
Bruce L MillerUniversity of California san francisco
Chiadi U OnyikeJohns Hopkins University
Leonard PetrucelliMayo Clinic
Rosa RademakersMayo Clinic
Leslie M ShawPerelman School of Medicine, University of Pennsylvania
Arthur W Toga
Arthur W Toga
John Q TrojanowskiPerelman School of Medicine, University of Pennsylvania
Adam L BoxerUniversity of California san francisco
Bradley F BoeveMayo Clinic
Joel H KramerUniversity of California san francisco
Howard J RosenUniversity of California san francisco
  • 1 - 24

Datasets

Release 1.2